Tuesday, September 24, 2013

"Motley Fool" cites Kalorama R&D Numbers

Kalorama's series on outsourcing in drug discovery and development is among our best selling series of market research information in the life sciences, recently Motley Fool picked up on our estimate of the size and growth of the R&D market in their story about the Top 10 Pharma R&D Budgets.

Roche and Pfizer top the list, with Pfizer showing a 23% increase over 2009. 

 According to research firm Kalorama Information, global R&D spending in the pharmaceutical sector increased from just $35.3 billion in 1996 to more than $95 billion in 2009, so we know the investable money is there. Let's have a look at the 10 biggest pharmaceuticals R&D budgets in fiscal 2012 and see how they compare to corporate R&D spending in 2009.

Kalorama's Research on Pharmaceutical R&D can be found here